Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
29.36
+0.17 (0.58%)
At close: Oct 23, 2026, 4:00 PM EDT
28.79
-0.57 (-1.94%)
After-hours: Oct 23, 2026, 4:44 PM EDT
Nanobiotix Employees
Nanobiotix had 98 employees as of June 30, 2026. The number of employees decreased by 2 or 2.00% since the number was reported on December 31, 2025.
Employees
98
Change
-2
Growth
-2.00%
Revenue / Employee
$134,135
Profits / Employee
-$616,302
Market Cap
1.47B
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 98 | -2 | -2.00% | 98 | 0 |
| Dec 31, 2025 | 100 | -8 | -7.41% | 100 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Ocular Therapeutix | 325 |
| ORIC Pharmaceuticals | 111 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
| Tyra Biosciences | 87 |
| GH Research | 73 |
NBTX News
- 21 hours ago - NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma - GlobeNewsWire
- 4 days ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 23 days ago - Nanobiotix Names Arnd Christ CFO As Rhijn Steps Down - Nasdaq
- 23 days ago - Nanobiotix (NBTX) Names Arnd Christ as CFO Amid Share Price Drop - GuruFocus
- 23 days ago - Nanobiotix appoints Arnd Christ CFO - TheFly
- 23 days ago - NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer - GlobeNewsWire
- 25 days ago - Nanobiotix S.A. (NBTX) Earnings Review: Clinical Progress Meets a Cash-Runway Test - AlphaStreet
- 4 weeks ago - Nanobiotix (NBTX) Faces High Price-to-Sales Valuation Amid Continued Losses - GuruFocus